Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender cate...
Saved in:
| Published in | Journal of cardiovascular magnetic resonance Vol. 19; no. 1; pp. 98 - 12 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Elsevier Inc
07.12.2017
BioMed Central BioMed Central Ltd Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1097-6647 1532-429X 1532-429X |
| DOI | 10.1186/s12968-017-0415-x |
Cover
| Abstract | Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality.
We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality.
There were 113 patients (median age 74 years, Q1-Q3: 62–82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09–7.86, P = 0.03).
Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. |
|---|---|
| AbstractList | Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality.
We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality.
There were 113 patients (median age 74 years, Q1-Q3: 62-82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09-7.86, P = 0.03).
Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality. Methods We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality. Results There were 113 patients (median age 74 years, Q1-Q3: 62–82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09–7.86, P = 0.03). Conclusions Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality.BACKGROUNDNon-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality.We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality.METHODSWe retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality.There were 113 patients (median age 74 years, Q1-Q3: 62-82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09-7.86, P = 0.03).RESULTSThere were 113 patients (median age 74 years, Q1-Q3: 62-82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09-7.86, P = 0.03).Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation.CONCLUSIONSSuspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality. Methods We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality. Results There were 113 patients (median age 74 years, Q1-Q3: 62-82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09-7.86, P = 0.03). Conclusions Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. Keywords: Aortic Stenosis, Cardiac Amyloidosis, Outcomes, Cardiovascular magnetic resonance Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality. We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality. There were 113 patients (median age 74 years, Q1-Q3: 62-82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09-7.86, P = 0.03). Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. Abstract Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence of clinically suspected CA in patients with moderate and severe AS referred for cardiovascular magnetic resonance (CMR) in age and gender categories, and assess associations between AS-CA and all-cause mortality. Methods We retrospectively identified consecutive AS patients defined by echocardiography referred for further CMR assessment of valvular, myocardial, and aortic disease. CMR identified CA based on typical late-gadolinium enhancement (LGE) patterns, and ancillary clinical evaluation identified suspected CA. Survival analysis with the Log rank test and Cox regression compared associations between CA and mortality. Results There were 113 patients (median age 74 years, Q1-Q3: 62–82 years), 96 (85%) with severe AS. Suspected CA was present in 9 patients (8%) all > 80 years. Among those over the median age of 74 years, the prevalence of CA was 9/57 (16%), and excluding women, the prevalence was 8/25 (32%). Low-flow, low-gradient physiology was very common in CA (7/9 patients or 78%). Over a median follow-up of 18 months, 40 deaths (35%) occurred. Mortality in AS + CA patients was higher than AS alone (56% vs. 20% at 1-year, log rank 15.0, P < 0.0001). Adjusting for aortic valve replacement modeled as a time-dependent covariate, Society of Thoracic Surgery predicted risk of mortality, left ventricular ejection fraction, CA remained associated with all-cause mortality (HR = 2.92, 95% CI = 1.09–7.86, P = 0.03). Conclusions Suspected CA appears prevalent among older male patients with AS, especially with low flow, low gradient AS, and associates with all-cause mortality. The importance of screening for CA in older AS patients and optimal treatment strategies in those with CA warrant further investigation, especially in the era of transcatheter aortic valve implantation. |
| ArticleNumber | 98 |
| Audience | Academic |
| Author | Soman, Prem Cavalcante, João L. Schelbert, Erik B. Fridman, Yaron Althouse, Andrew D. Sharbaugh, Michael S. Lee, Joon S. Rijal, Shasank Schindler, John T. Forman, Daniel E. Abdelkarim, Islam Gleason, Thomas G. |
| Author_xml | – sequence: 1 givenname: João L. surname: Cavalcante fullname: Cavalcante, João L. email: cavalcantejl@upmc.edu organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 2 givenname: Shasank surname: Rijal fullname: Rijal, Shasank organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 3 givenname: Islam surname: Abdelkarim fullname: Abdelkarim, Islam organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 4 givenname: Andrew D. surname: Althouse fullname: Althouse, Andrew D. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 5 givenname: Michael S. surname: Sharbaugh fullname: Sharbaugh, Michael S. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 6 givenname: Yaron surname: Fridman fullname: Fridman, Yaron organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 7 givenname: Prem surname: Soman fullname: Soman, Prem organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 8 givenname: Daniel E. surname: Forman fullname: Forman, Daniel E. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 9 givenname: John T. surname: Schindler fullname: Schindler, John T. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 10 givenname: Thomas G. surname: Gleason fullname: Gleason, Thomas G. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 11 givenname: Joon S. surname: Lee fullname: Lee, Joon S. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA – sequence: 12 givenname: Erik B. surname: Schelbert fullname: Schelbert, Erik B. organization: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 200 Lothrop Street, Scaife Hall S-558, 15213, Pittsburgh, PA, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29212513$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kl1r2zAUhs3oWD-2H7CbYRiM3biTbH1YN4MS9lEo7GaD3YljWU6UKVImOWn773cSd6UZI1hgcfQ-r3Sk97w4CTHYonhNySWlrfiQaa1EWxEqK8Ior-6eFWeUN3XFavXzBOdEyUoIJk-L85yXhFAliXxRnNaqpjWnzVlhZpB6B6aE1b2Pro_Z5RLHOtkteBvG0oUy-t6mcg2jw0Iub924KCGm0ZkyjzbsGQh9aSAlZ1EQU7ZoEef7tZfF8wF8tq8e_hfFj8-fvs--VjffvlzPrm4qI7gYKwXCAJhmAGpk3bK6JcCJ7FQDlLcMhJKWStVzw4nqmFRNxy3DSaM63ne0uSiuJ98-wlKvk1tButcRnN4XYppr2B3aW90MVChgktTWMgadIq0RtKGStZz2INHr4-S13nQr2xtsPIE_MD1cCW6h53GrucRLbhUavH8wSPH3xuZRr1w21nsINm6yRhUjRIqGo_TtJJ3jjWsXhoiOZifXV5yJRkgqBKou_6PCr7crZzAYg8P6AfDuCbCw4MdFjn4zuhjyofDN014fm_ybEhTQSWBSzDnZ4VFCid4lUU9J1JhEvUuivkNG_sMYN8Jubzy280fJeiIz7hLmNull3KSAyTkKqQmyGLCtQ8h4F5wB_8ve4_u7I-wfVsoEvQ |
| CitedBy_id | crossref_primary_10_36660_abchf_20210027 crossref_primary_10_1016_j_jcmg_2022_08_006 crossref_primary_10_1016_j_carrev_2023_08_008 crossref_primary_10_1093_ehjci_jeac086 crossref_primary_10_1007_s10554_020_02146_3 crossref_primary_10_1016_j_ijcard_2023_131301 crossref_primary_10_1111_jocs_15230 crossref_primary_10_1016_j_regg_2022_10_005 crossref_primary_10_1093_eurheartj_ehac504 crossref_primary_10_1186_s12968_019_0594_8 crossref_primary_10_1016_j_ccl_2024_09_006 crossref_primary_10_1016_j_jacc_2020_03_042 crossref_primary_10_36660_ijcs_20240064 crossref_primary_10_1016_j_jacc_2019_09_056 crossref_primary_10_1093_eurheartj_ehaa170 crossref_primary_10_1186_s12947_023_00299_4 crossref_primary_10_1002_ejhf_1798 crossref_primary_10_1016_j_ijcha_2020_100519 crossref_primary_10_1186_s12947_019_0182_y crossref_primary_10_1016_j_jacadv_2023_100255 crossref_primary_10_1016_j_jacadv_2023_100256 crossref_primary_10_3390_jcm13030671 crossref_primary_10_1016_j_carrev_2020_06_005 crossref_primary_10_1093_eurheartj_ehab368 crossref_primary_10_1016_j_jcmg_2019_02_034 crossref_primary_10_1161_CIRCHEARTFAILURE_123_010603 crossref_primary_10_62347_HJHT9161 crossref_primary_10_1016_j_jcct_2024_09_011 crossref_primary_10_1016_j_carpath_2024_107674 crossref_primary_10_1161_CIRCIMAGING_122_014549 crossref_primary_10_1007_s40134_023_00419_y crossref_primary_10_1136_heartjnl_2019_315211 crossref_primary_10_1001_jamacardio_2021_5916 crossref_primary_10_3389_fcvm_2023_1108696 crossref_primary_10_37549_AR2935 crossref_primary_10_1016_j_jcmg_2020_07_045 crossref_primary_10_1177_30494826241296676 crossref_primary_10_1186_s13019_022_01776_z crossref_primary_10_12688_f1000research_75232_1 crossref_primary_10_1111_jocs_15629 crossref_primary_10_2174_1573403X15666190722154152 crossref_primary_10_1007_s10554_022_02774_x crossref_primary_10_1007_s12181_020_00382_4 crossref_primary_10_1007_s11897_020_00481_z crossref_primary_10_3390_diagnostics14192249 crossref_primary_10_1002_jmri_26204 crossref_primary_10_1093_ehjci_jead153 crossref_primary_10_1002_ehf2_13909 crossref_primary_10_4326_jjcvs_51_157 crossref_primary_10_1016_j_cjca_2025_02_031 crossref_primary_10_1016_j_jcin_2020_03_011 crossref_primary_10_1016_j_repc_2024_11_009 crossref_primary_10_1136_heartjnl_2019_314987 crossref_primary_10_1016_j_jcmg_2020_07_011 crossref_primary_10_1016_j_jcin_2020_03_019 crossref_primary_10_1007_s00108_022_01449_y crossref_primary_10_1007_s00392_020_01799_3 crossref_primary_10_4103_JCC_JCC_29_24 crossref_primary_10_1002_ejhf_2589 crossref_primary_10_1007_s00259_023_06374_2 crossref_primary_10_2147_CIA_S265103 crossref_primary_10_3389_fphar_2020_01024 crossref_primary_10_3390_jcm12185804 crossref_primary_10_1016_j_jaccao_2021_09_004 crossref_primary_10_1016_j_ijcha_2021_100741 crossref_primary_10_1016_j_crad_2019_11_011 crossref_primary_10_1016_j_ijcard_2024_131854 crossref_primary_10_1080_13506129_2022_2159369 crossref_primary_10_3390_biomedicines10071566 crossref_primary_10_1186_s12968_018_0518_z crossref_primary_10_1093_eurheartj_ehaa458 crossref_primary_10_1007_s00508_020_01781_z crossref_primary_10_1016_j_jcmg_2020_05_029 crossref_primary_10_2139_ssrn_3951137 crossref_primary_10_1161_JAHA_123_033251 crossref_primary_10_1002_ehf2_13876 crossref_primary_10_1016_j_amjcard_2023_05_010 crossref_primary_10_1002_ejhf_2333 crossref_primary_10_1007_s10554_020_02059_1 crossref_primary_10_1007_s40119_020_00169_4 crossref_primary_10_1016_j_carrev_2023_07_002 crossref_primary_10_1253_circj_CJ_20_1064 crossref_primary_10_1016_j_echo_2019_05_003 crossref_primary_10_1038_s41569_020_0334_7 crossref_primary_10_1016_j_jacc_2020_11_007 crossref_primary_10_1080_24748706_2019_1678794 crossref_primary_10_1016_j_jacc_2020_11_006 crossref_primary_10_1016_j_amjcard_2023_04_003 crossref_primary_10_1093_eurheartj_ehaa768 crossref_primary_10_1259_bjr_20190836 crossref_primary_10_1016_j_hfc_2021_07_006 crossref_primary_10_1016_j_jacc_2018_07_092 crossref_primary_10_1093_ehjopen_oead106 crossref_primary_10_4326_jjcvs_50_5_xv crossref_primary_10_1007_s10741_023_10350_1 crossref_primary_10_1016_j_carrev_2022_04_027 crossref_primary_10_1016_j_ijcha_2020_100551 crossref_primary_10_1016_j_jaccao_2021_06_006 crossref_primary_10_1016_j_jaccao_2021_08_008 crossref_primary_10_1016_j_hjc_2019_10_004 crossref_primary_10_1007_s11936_023_00976_7 crossref_primary_10_1161_CIRCIMAGING_119_010249 crossref_primary_10_2217_fca_2018_0078 crossref_primary_10_1186_s13023_025_03547_0 crossref_primary_10_1002_ejhf_1756 crossref_primary_10_3390_diagnostics11050834 crossref_primary_10_1016_j_amjcard_2024_10_009 crossref_primary_10_1016_j_jaccao_2019_11_006 crossref_primary_10_15420_icr_2021_04 crossref_primary_10_1016_j_cpcardiol_2024_102417 crossref_primary_10_1080_24748706_2021_1881194 crossref_primary_10_1097_JS9_0000000000001271 crossref_primary_10_1007_s12181_019_00344_5 crossref_primary_10_1038_s41467_021_27416_z crossref_primary_10_1007_s40119_019_00160_8 crossref_primary_10_1016_j_ijcard_2025_133110 crossref_primary_10_1016_j_revmed_2020_07_002 crossref_primary_10_1007_s12410_019_9518_0 crossref_primary_10_1161_CIRCIMAGING_119_010358 crossref_primary_10_1080_14796678_2024_2393031 crossref_primary_10_33290_jtvt_oa_22_0007 crossref_primary_10_1111_pace_14375 crossref_primary_10_26442_00403660_2023_01_202081 crossref_primary_10_1016_j_hfc_2023_02_005 crossref_primary_10_1016_j_jcmg_2020_08_023 crossref_primary_10_1093_eurheartj_ehaa549 crossref_primary_10_1177_1178623X19843519 crossref_primary_10_1093_ehjci_jeac146 crossref_primary_10_1161_CIRCULATIONAHA_118_036600 crossref_primary_10_1016_j_jaccao_2020_10_007 crossref_primary_10_1016_j_amjcard_2022_10_057 crossref_primary_10_3389_fcvm_2020_590557 crossref_primary_10_3390_jpm11121268 crossref_primary_10_1002_ehf2_13667 crossref_primary_10_1002_ejhf_1974 crossref_primary_10_1016_j_carrev_2022_07_011 crossref_primary_10_1136_heartjnl_2021_319922 crossref_primary_10_1016_j_jacc_2019_04_003 crossref_primary_10_3390_biom13111661 crossref_primary_10_1161_JAHA_124_034723 crossref_primary_10_1016_j_ahjo_2024_100444 crossref_primary_10_2169_internalmedicine_3870_19 crossref_primary_10_1016_j_recesp_2021_11_027 crossref_primary_10_1002_ehf2_12986 crossref_primary_10_3389_fmed_2022_858281 crossref_primary_10_1038_s41467_021_22877_8 crossref_primary_10_1002_ejhf_2532 crossref_primary_10_2217_fca_2021_0118 crossref_primary_10_1038_s41467_021_23274_x crossref_primary_10_5334_gh_1262 crossref_primary_10_1016_j_acvd_2024_04_007 crossref_primary_10_1016_j_hjc_2021_11_001 crossref_primary_10_1111_anec_12967 crossref_primary_10_1016_j_jcmg_2022_09_010 crossref_primary_10_1016_j_heliyon_2023_e17336 |
| Cites_doi | 10.1016/j.jcmg.2009.08.008 10.1093/ehjci/jeu158 10.1161/CIRCULATIONAHA.116.021612 10.3109/07853890.2015.1068949 10.1186/1532-429X-13-16 10.1016/j.jcmg.2014.03.004 10.1148/radiol.2015141744 10.1016/j.jcmg.2015.10.023 10.1186/1532-429X-10-54 10.1016/j.echo.2016.01.011 10.1136/heartjnl-2012-302353 10.1111/petr.12986 10.1016/j.jcmg.2013.10.008 10.1161/JAHA.115.002613 10.1161/CIR.0000000000000031 10.1016/0002-9343(83)90443-6 10.1161/CIRCIMAGING.113.001396 10.1161/CIRCULATIONAHA.115.016567 10.1016/j.jcmg.2015.04.012 10.1093/ejechocard/jen303 10.1161/CIRCIMAGING.112.000132 10.1016/j.jcin.2012.03.012 10.1161/01.CIR.0000152819.97857.9D 10.1161/CIRCIMAGING.116.005066 10.1093/eurheartj/ehw033 10.1093/eurheartj/ehx350 10.1016/j.jacc.2013.05.015 10.1016/j.jcmg.2009.09.023 10.1016/j.jacc.2012.02.093 10.1016/j.echo.2014.10.003 10.1016/j.jcct.2015.07.001 10.1016/j.jcmg.2012.11.013 10.1093/ehjci/jev342 10.1093/eurheartj/ehu444 10.1080/07853890701842988 |
| ContentType | Journal Article |
| Copyright | 2017 © 2017 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance The Author(s). 2017 COPYRIGHT 2017 BioMed Central Ltd. |
| Copyright_xml | – notice: 2017 © 2017 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance – notice: The Author(s). 2017 – notice: COPYRIGHT 2017 BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1186/s12968-017-0415-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals (Freely Accessible) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-429X |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_3f169a4702ee44ab908c613174851da7 PMC5719789 A546367166 29212513 10_1186_s12968_017_0415_x S1097664723011328 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: P30 AG024827 |
| GroupedDBID | --- .1- .FO 0R~ 29K 2WC 36B 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AALRI AAWTL AAXUO AAYWO ABDBF ABUWG ACGEJ ACGFO ACGFS ACIWK ACPRK ACVFH ADBBV ADCNI ADCVX ADRAZ ADUKV ADVLN ADXPE AENEX AEUPX AFJKZ AFKRA AFPKN AFPUW AFRAH AFRHN AHBYD AHMBA AHSBF AHYZX AIGII AITUG AJUYK AJWEG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ AMTXH AOIJS ARAPS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 D-I DIK DU5 E3Z EAP EBS EJD EMB EMK EMOBN EST ESX F5P FDB FRP FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR IHW INR KQ8 LK8 M1P M41 M48 M7P O5R O5S OK1 OVT P2P P62 P6G PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TDBHL TFW TR2 TUS UKHRP Z5R ZCN EBLON 2VQ 4.4 AAYXX ACUHS AFCTW ALIPV APXCP AWYRJ CAG CITATION COF EBC EBD HZ~ IPNFZ O9- RIG -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF EAD ECM EIF INH M~E NPM PMFND 7X8 5PM |
| ID | FETCH-LOGICAL-c656t-9a6caac3fa1c7284280a507b93a1584a697e179d5c509b4793b5e4b4739b5db13 |
| IEDL.DBID | M48 |
| ISSN | 1097-6647 1532-429X |
| IngestDate | Wed Aug 27 01:20:23 EDT 2025 Thu Aug 21 14:09:53 EDT 2025 Sun Sep 28 05:19:05 EDT 2025 Tue Jun 17 21:01:42 EDT 2025 Tue Jun 10 20:44:48 EDT 2025 Thu May 22 21:23:47 EDT 2025 Wed Feb 19 02:08:55 EST 2025 Tue Jul 01 02:54:53 EDT 2025 Thu Apr 24 23:01:37 EDT 2025 Sat Sep 06 07:28:48 EDT 2025 Tue Aug 26 20:25:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Aortic Stenosis Cardiovascular magnetic resonance Cardiac Amyloidosis Outcomes |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c656t-9a6caac3fa1c7284280a507b93a1584a697e179d5c509b4793b5e4b4739b5db13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.1186/s12968-017-0415-x |
| PMID | 29212513 |
| PQID | 1974007635 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3f169a4702ee44ab908c613174851da7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5719789 proquest_miscellaneous_1974007635 gale_infotracmisc_A546367166 gale_infotracacademiconefile_A546367166 gale_healthsolutions_A546367166 pubmed_primary_29212513 crossref_primary_10_1186_s12968_017_0415_x crossref_citationtrail_10_1186_s12968_017_0415_x springer_journals_10_1186_s12968_017_0415_x elsevier_clinicalkey_doi_10_1186_s12968_017_0415_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-12-07 |
| PublicationDateYYYYMMDD | 2017-12-07 |
| PublicationDate_xml | – month: 12 year: 2017 text: 2017-12-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of cardiovascular magnetic resonance |
| PublicationTitleAbbrev | J Cardiovasc Magn Reson |
| PublicationTitleAlternate | J Cardiovasc Magn Reson |
| PublicationYear | 2017 |
| Publisher | Elsevier Inc BioMed Central BioMed Central Ltd Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: BioMed Central – name: BioMed Central Ltd – name: Elsevier |
| References | Dweck, Boon, Newby (bib36) 2012; 60 Sperry, Jones, Vranian, Hanna, Jaber (bib5) 2016; 9 Maceira, Prasad, Hawkins, Roughton, Pennell (bib15) 2008; 10 Schelbert, Testa, Meier, Ceyrolles, Levenson, Blair, Kellman, Jones, Ludwig, Schwartzman (bib31) 2011; 13 Tanskanen, Peuralinna, Polvikoski, Notkola, Sulkava, Hardy, Singleton, Kiuru-Enari, Paetau, Tienari, Myllykangas (bib1) 2008; 40 Gillmore, Maurer, Falk, Merlini, Damy, Dispenzieri, Wechalekar, Berk, Quarta, Grogan (bib26) 2016; 133 Hawkins, Ando, Dispenzeri, Gonzalez-Duarte, Adams, Suhr (bib32) 2015; 47 Karamitsos, Piechnik, Banypersad, Fontana, Ntusi, Ferreira, Whelan, Myerson, Robson, Hawkins (bib34) 2013; 6 Phelan, Collier, Thavendiranathan, Popovic, Hanna, Plana, Marwick, Thomas (bib24) 2012; 98 Bokhari, Castano, Pozniakoff, Deslisle, Latif (bib25) 2013; 6 Baumgartner, Hung, Bermejo, Chambers, Evangelista, Griffin, Iung, Otto, Pellikka, Quinones (bib18) 2009; 10 Feingold, Salgado, Reyes-Mugica, Drant, Miller, Kennedy, Kellman, Schelbert, Wong (bib22) 2017; 21 Austin, Tang, Rodriguez, Tan, Flamm, Taylor, Starling, Desai (bib13) 2009; 2 Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, Roberts N, Hutt DF, Rowczenio DM, Whelan CJ, et al. Occult Transthyretin cardiac Amyloid in severe Calcific aortic Stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9(8). Castano, Narotsky, Hamid, Khalique, Morgenstern, DeLuca, Rubin, Chiuzan, Nazif, Vahl (bib33) 2017; 38 Haloui, Salaun, Maysou, Dehaene, Habib (bib4) 2016; 17 Falk, Quarta, Dorbala (bib10) 2014; 7 Schelbert, Piehler, Zareba, Moon, Ugander, Messroghli, Valeti, Chang, Shroff, Diez (bib21) 2015; 4 Galat, Guellich, Bodez, Slama, Dijos, Zeitoun, Milleron, Attias, Dubois-Rande, Mohty (bib6) 2016; 37 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014(63):2438–88. Osnabrugge, Mylotte, Head, Van Mieghem, Nkomo, LeReun, Bogers, Piazza, Kappetein (bib8) 2013; 62 Lang, Badano, Mor-Avi, Afilalo, Armstrong, Ernande, Flachskampf, Foster, Goldstein, Kuznetsova (bib16) 2015; 28 Longhi, Lorenzini, Gagliardi, Milandri, Marzocchi, Marrozzini, Saia, Ortolani, Biagini, Guidalotti (bib3) 2016; 9 Nietlispach, Webb, Ye, Cheung, Lichtenstein, Carere, Gurvitch, Thompson, Ostry, Matzke, Allard (bib2) 2012; 5 Syed, Glockner, Feng, Araoz, Martinez, Edwards, Gertz, Dispenzieri, Oh, Bellavia (bib12) 2010; 3 Longhi, Guidalotti, Quarta, Gagliardi, Milandri, Lorenzini, Potena, Leone, Bartolomei, Pastorelli (bib27) 2014; 7 Banypersad, Fontana, Maestrini, Sado, Captur, Petrie, Piechnik, Whelan, Herrey, Gillmore (bib29) 2015; 36 Maceira, Joshi, Prasad, Moon, Perugini, Harding, Sheppard, Poole-Wilson, Hawkins, Pennell (bib11) 2005; 111 Gillmore, Maurer, Falk, Merlini, Damy, Dispenzieri, Wechalekar, Berk, Quarta, Grogan (bib20) 2016; 133 Fontana, Banypersad, Treibel, Maestrini, Sado, White, Pica, Castelletti, Piechnik, Robson (bib35) 2014; 7 Di Bella, Pizzino, Minutoli, Zito, Donato, Dattilo, Oreto, Baldari, Vita, Khandheria, Carerj (bib9) 2014; 15 Treibel, Bandula, Fontana, White, Gilbertson, Herrey, Gillmore, Punwani, Hawkins, Taylor, Moon (bib28) 2015; 9 Fontana, Banypersad, Treibel, Abdel-Gadir, Maestrini, Lane, Gilbertson, Hutt, Lachmann, Whelan (bib30) 2015; 277 Nagueh, Smiseth, Appleton, Byrd, Dokainish, Edvardsen, Flachskampf, Gillebert, Klein, Lancellotti (bib17) 2016; 29 Fontana, Pica, Reant, Abdel-Gadir, Treibel, Banypersad, Maestrini, Barcella, Rosmini, Bulluck (bib14) 2015; 132 Cornwell, Murdoch, Kyle, Westermark, Pitkanen (bib23) 1983; 75 Sperry (10.1186/s12968-017-0415-x_bib5) 2016; 9 Haloui (10.1186/s12968-017-0415-x_bib4) 2016; 17 Karamitsos (10.1186/s12968-017-0415-x_bib34) 2013; 6 Austin (10.1186/s12968-017-0415-x_bib13) 2009; 2 Gillmore (10.1186/s12968-017-0415-x_bib26) 2016; 133 Maceira (10.1186/s12968-017-0415-x_bib15) 2008; 10 Galat (10.1186/s12968-017-0415-x_bib6) 2016; 37 Dweck (10.1186/s12968-017-0415-x_bib36) 2012; 60 Longhi (10.1186/s12968-017-0415-x_bib27) 2014; 7 Hawkins (10.1186/s12968-017-0415-x_bib32) 2015; 47 Nagueh (10.1186/s12968-017-0415-x_bib17) 2016; 29 Phelan (10.1186/s12968-017-0415-x_bib24) 2012; 98 Feingold (10.1186/s12968-017-0415-x_bib22) 2017; 21 Castano (10.1186/s12968-017-0415-x_bib33) 2017; 38 Osnabrugge (10.1186/s12968-017-0415-x_bib8) 2013; 62 Baumgartner (10.1186/s12968-017-0415-x_bib18) 2009; 10 Bokhari (10.1186/s12968-017-0415-x_bib25) 2013; 6 Schelbert (10.1186/s12968-017-0415-x_bib31) 2011; 13 Treibel (10.1186/s12968-017-0415-x_bib28) 2015; 9 Di Bella (10.1186/s12968-017-0415-x_bib9) 2014; 15 Cornwell (10.1186/s12968-017-0415-x_bib23) 1983; 75 10.1186/s12968-017-0415-x_bib7 Maceira (10.1186/s12968-017-0415-x_bib11) 2005; 111 Gillmore (10.1186/s12968-017-0415-x_bib20) 2016; 133 Lang (10.1186/s12968-017-0415-x_bib16) 2015; 28 Falk (10.1186/s12968-017-0415-x_bib10) 2014; 7 Fontana (10.1186/s12968-017-0415-x_bib35) 2014; 7 Tanskanen (10.1186/s12968-017-0415-x_bib1) 2008; 40 Fontana (10.1186/s12968-017-0415-x_bib14) 2015; 132 Syed (10.1186/s12968-017-0415-x_bib12) 2010; 3 Schelbert (10.1186/s12968-017-0415-x_bib21) 2015; 4 10.1186/s12968-017-0415-x_bib19 Banypersad (10.1186/s12968-017-0415-x_bib29) 2015; 36 Fontana (10.1186/s12968-017-0415-x_bib30) 2015; 277 Longhi (10.1186/s12968-017-0415-x_bib3) 2016; 9 Nietlispach (10.1186/s12968-017-0415-x_bib2) 2012; 5 |
| References_xml | – volume: 10 start-page: 54 year: 2008 ident: bib15 article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis publication-title: J Cardiovasc Magn Reson – volume: 47 start-page: 625 year: 2015 end-page: 638 ident: bib32 article-title: Evolving landscape in the management of transthyretin amyloidosis publication-title: Ann Med – volume: 6 start-page: 195 year: 2013 end-page: 201 ident: bib25 article-title: Maurer MS: (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses publication-title: Circ Cardiovasc Imaging – volume: 40 start-page: 232 year: 2008 end-page: 239 ident: bib1 article-title: Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study publication-title: Ann Med – volume: 15 start-page: 1307 year: 2014 end-page: 1315 ident: bib9 article-title: The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease publication-title: Eur Heart J Cardiovasc Imaging – volume: 62 start-page: 1002 year: 2013 end-page: 1012 ident: bib8 article-title: Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study publication-title: J Am Coll Cardiol – volume: 5 start-page: 582 year: 2012 end-page: 590 ident: bib2 article-title: Pathology of transcatheter valve therapy publication-title: JACC Cardiovasc Interv – volume: 37 start-page: 3525 year: 2016 end-page: 3531 ident: bib6 article-title: Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? publication-title: Eur Heart J – volume: 277 start-page: 388 year: 2015 end-page: 397 ident: bib30 article-title: Differential Myocyte responses in patients with cardiac Transthyretin Amyloidosis and light-chain Amyloidosis: a cardiac MR imaging study publication-title: Radiology – volume: 3 start-page: 155 year: 2010 end-page: 164 ident: bib12 article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis publication-title: JACC Cardiovasc Imaging – volume: 10 start-page: 1 year: 2009 end-page: 25 ident: bib18 article-title: Eae/ASE: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice publication-title: Eur J Echocardiogr – volume: 133 start-page: 2404 year: 2016 end-page: 2412 ident: bib20 article-title: Nonbiopsy diagnosis of cardiac Transthyretin Amyloidosis publication-title: Circulation – volume: 7 start-page: 531 year: 2014 end-page: 532 ident: bib27 article-title: Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy publication-title: JACC Cardiovasc Imaging – volume: 60 start-page: 1854 year: 2012 end-page: 1863 ident: bib36 article-title: Calcific aortic stenosis: a disease of the valve and the myocardium publication-title: J Am Coll Cardiol – volume: 13 start-page: 16 year: 2011 ident: bib31 article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus publication-title: J Cardiovasc Magn Reson – reference: Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014(63):2438–88. – volume: 7 start-page: 552 year: 2014 end-page: 562 ident: bib10 article-title: How to image cardiac amyloidosis publication-title: Circ Cardiovasc Imaging – volume: 17 start-page: 383 year: 2016 ident: bib4 article-title: Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction publication-title: Eur Heart J Cardiovasc Imaging – volume: 2 start-page: 1369 year: 2009 end-page: 1377 ident: bib13 article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis publication-title: JACC Cardiovasc Imaging – volume: 133 start-page: 2404 year: 2016 end-page: 2412 ident: bib26 article-title: Non-biopsy diagnosis of cardiac Transthyretin Amyloidosis publication-title: Circulation – volume: 4 year: 2015 ident: bib21 article-title: Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the Spectrum of ejection fraction and heart failure stage publication-title: J Am Heart Assoc – volume: 36 start-page: 244 year: 2015 end-page: 251 ident: bib29 article-title: T1 mapping and survival in systemic light-chain amyloidosis publication-title: Eur Heart J – volume: 132 start-page: 1570 year: 2015 end-page: 1579 ident: bib14 article-title: Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac Amyloidosis publication-title: Circulation – volume: 9 start-page: 325 year: 2016 end-page: 327 ident: bib3 article-title: Coexistence of degenerative aortic Stenosis and wild-type Transthyretin-related cardiac Amyloidosis publication-title: JACC Cardiovasc Imaging – volume: 111 start-page: 186 year: 2005 end-page: 193 ident: bib11 article-title: Cardiovascular magnetic resonance in cardiac amyloidosis publication-title: Circulation – volume: 29 start-page: 277 year: 2016 end-page: 314 ident: bib17 article-title: Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging publication-title: J Am Soc Echocardiogr – volume: 7 start-page: 157 year: 2014 end-page: 165 ident: bib35 article-title: Native T1 mapping in transthyretin amyloidosis publication-title: JACC Cardiovasc Imaging – volume: 9 start-page: 904 year: 2016 end-page: 906 ident: bib5 article-title: Recognizing Transthyretin cardiac Amyloidosis in patients with aortic Stenosis: impact on prognosis publication-title: JACC Cardiovasc Imaging – volume: 21 year: 2017 ident: bib22 article-title: Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype publication-title: Pediatr Transplant – volume: 6 start-page: 488 year: 2013 end-page: 497 ident: bib34 article-title: Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis publication-title: JACC Cardiovasc Imaging – volume: 98 start-page: 1442 year: 2012 end-page: 1448 ident: bib24 article-title: Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis publication-title: Heart – volume: 28 start-page: 1 year: 2015 end-page: 39 ident: bib16 article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging publication-title: J Am Soc Echocardiogr – reference: Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, Roberts N, Hutt DF, Rowczenio DM, Whelan CJ, et al. Occult Transthyretin cardiac Amyloid in severe Calcific aortic Stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9(8). – volume: 75 start-page: 618 year: 1983 end-page: 623 ident: bib23 article-title: Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation publication-title: Am J Med – volume: 9 start-page: 585 year: 2015 end-page: 592 ident: bib28 article-title: Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis publication-title: J Cardiovasc Comput Tomogr – volume: 38 start-page: 2879 year: 2017 end-page: 2887 ident: bib33 article-title: Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement publication-title: Eur Heart J – volume: 2 start-page: 1369 year: 2009 ident: 10.1186/s12968-017-0415-x_bib13 article-title: Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2009.08.008 – volume: 15 start-page: 1307 year: 2014 ident: 10.1186/s12968-017-0415-x_bib9 article-title: The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jeu158 – volume: 133 start-page: 2404 issue: 24 year: 2016 ident: 10.1186/s12968-017-0415-x_bib26 article-title: Non-biopsy diagnosis of cardiac Transthyretin Amyloidosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.021612 – volume: 47 start-page: 625 year: 2015 ident: 10.1186/s12968-017-0415-x_bib32 article-title: Evolving landscape in the management of transthyretin amyloidosis publication-title: Ann Med doi: 10.3109/07853890.2015.1068949 – volume: 13 start-page: 16 year: 2011 ident: 10.1186/s12968-017-0415-x_bib31 article-title: Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-13-16 – volume: 133 start-page: 2404 year: 2016 ident: 10.1186/s12968-017-0415-x_bib20 article-title: Nonbiopsy diagnosis of cardiac Transthyretin Amyloidosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.021612 – volume: 7 start-page: 531 year: 2014 ident: 10.1186/s12968-017-0415-x_bib27 article-title: Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2014.03.004 – volume: 277 start-page: 388 year: 2015 ident: 10.1186/s12968-017-0415-x_bib30 article-title: Differential Myocyte responses in patients with cardiac Transthyretin Amyloidosis and light-chain Amyloidosis: a cardiac MR imaging study publication-title: Radiology doi: 10.1148/radiol.2015141744 – volume: 9 start-page: 904 issue: 7 year: 2016 ident: 10.1186/s12968-017-0415-x_bib5 article-title: Recognizing Transthyretin cardiac Amyloidosis in patients with aortic Stenosis: impact on prognosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2015.10.023 – volume: 10 start-page: 54 year: 2008 ident: 10.1186/s12968-017-0415-x_bib15 article-title: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-10-54 – volume: 29 start-page: 277 year: 2016 ident: 10.1186/s12968-017-0415-x_bib17 article-title: Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2016.01.011 – volume: 98 start-page: 1442 year: 2012 ident: 10.1186/s12968-017-0415-x_bib24 article-title: Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis publication-title: Heart doi: 10.1136/heartjnl-2012-302353 – volume: 21 issue: 5 year: 2017 ident: 10.1186/s12968-017-0415-x_bib22 article-title: Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype publication-title: Pediatr Transplant doi: 10.1111/petr.12986 – volume: 7 start-page: 157 year: 2014 ident: 10.1186/s12968-017-0415-x_bib35 article-title: Native T1 mapping in transthyretin amyloidosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2013.10.008 – volume: 4 issue: 12 year: 2015 ident: 10.1186/s12968-017-0415-x_bib21 article-title: Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the Spectrum of ejection fraction and heart failure stage publication-title: J Am Heart Assoc doi: 10.1161/JAHA.115.002613 – ident: 10.1186/s12968-017-0415-x_bib19 doi: 10.1161/CIR.0000000000000031 – volume: 75 start-page: 618 year: 1983 ident: 10.1186/s12968-017-0415-x_bib23 article-title: Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation publication-title: Am J Med doi: 10.1016/0002-9343(83)90443-6 – volume: 7 start-page: 552 year: 2014 ident: 10.1186/s12968-017-0415-x_bib10 article-title: How to image cardiac amyloidosis publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.113.001396 – volume: 132 start-page: 1570 year: 2015 ident: 10.1186/s12968-017-0415-x_bib14 article-title: Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac Amyloidosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.016567 – volume: 9 start-page: 325 year: 2016 ident: 10.1186/s12968-017-0415-x_bib3 article-title: Coexistence of degenerative aortic Stenosis and wild-type Transthyretin-related cardiac Amyloidosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2015.04.012 – volume: 10 start-page: 1 year: 2009 ident: 10.1186/s12968-017-0415-x_bib18 article-title: Eae/ASE: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice publication-title: Eur J Echocardiogr doi: 10.1093/ejechocard/jen303 – volume: 6 start-page: 195 year: 2013 ident: 10.1186/s12968-017-0415-x_bib25 article-title: Maurer MS: (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses publication-title: Circ Cardiovasc Imaging doi: 10.1161/CIRCIMAGING.112.000132 – volume: 5 start-page: 582 year: 2012 ident: 10.1186/s12968-017-0415-x_bib2 article-title: Pathology of transcatheter valve therapy publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2012.03.012 – volume: 111 start-page: 186 year: 2005 ident: 10.1186/s12968-017-0415-x_bib11 article-title: Cardiovascular magnetic resonance in cardiac amyloidosis publication-title: Circulation doi: 10.1161/01.CIR.0000152819.97857.9D – ident: 10.1186/s12968-017-0415-x_bib7 doi: 10.1161/CIRCIMAGING.116.005066 – volume: 37 start-page: 3525 issue: 47 year: 2016 ident: 10.1186/s12968-017-0415-x_bib6 article-title: Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw033 – volume: 38 start-page: 2879 year: 2017 ident: 10.1186/s12968-017-0415-x_bib33 article-title: Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx350 – volume: 62 start-page: 1002 year: 2013 ident: 10.1186/s12968-017-0415-x_bib8 article-title: Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.05.015 – volume: 3 start-page: 155 year: 2010 ident: 10.1186/s12968-017-0415-x_bib12 article-title: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2009.09.023 – volume: 60 start-page: 1854 year: 2012 ident: 10.1186/s12968-017-0415-x_bib36 article-title: Calcific aortic stenosis: a disease of the valve and the myocardium publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.02.093 – volume: 28 start-page: 1 year: 2015 ident: 10.1186/s12968-017-0415-x_bib16 article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2014.10.003 – volume: 9 start-page: 585 year: 2015 ident: 10.1186/s12968-017-0415-x_bib28 article-title: Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis publication-title: J Cardiovasc Comput Tomogr doi: 10.1016/j.jcct.2015.07.001 – volume: 6 start-page: 488 year: 2013 ident: 10.1186/s12968-017-0415-x_bib34 article-title: Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2012.11.013 – volume: 17 start-page: 383 year: 2016 ident: 10.1186/s12968-017-0415-x_bib4 article-title: Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jev342 – volume: 36 start-page: 244 year: 2015 ident: 10.1186/s12968-017-0415-x_bib29 article-title: T1 mapping and survival in systemic light-chain amyloidosis publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu444 – volume: 40 start-page: 232 year: 2008 ident: 10.1186/s12968-017-0415-x_bib1 article-title: Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study publication-title: Ann Med doi: 10.1080/07853890701842988 |
| SSID | ssj0019707 |
| Score | 2.551962 |
| Snippet | Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the prevalence... Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the... Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to estimate the... Abstract Background Non-invasive cardiac imaging allows detection of cardiac amyloidosis (CA) in patients with aortic stenosis (AS). Our objective was to... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 98 |
| SubjectTerms | Age Factors Aged Aged, 80 and over Amyloidosis Amyloidosis - diagnostic imaging Amyloidosis - epidemiology Amyloidosis - mortality Angiology Aortic Stenosis Aortic valve stenosis Aortic Valve Stenosis - diagnostic imaging Aortic Valve Stenosis - epidemiology Aortic Valve Stenosis - mortality Aortic Valve Stenosis - surgery Cardiac Amyloidosis Cardiology Cardiomyopathies - diagnostic imaging Cardiomyopathies - epidemiology Cardiomyopathies - mortality Cardiovascular magnetic resonance Chi-Square Distribution Comorbidity Comparative analysis Contrast Media - administration & dosage Echocardiography, Doppler Elderly patients Female Gadolinium - administration & dosage Health aspects Heart Valve Prosthesis Implantation Heterocyclic Compounds - administration & dosage Humans Imaging Kaplan-Meier Estimate Magnetic Resonance Imaging Male Medicine Medicine & Public Health Middle Aged Mortality Multivariate Analysis Organometallic Compounds - administration & dosage Outcomes Pennsylvania - epidemiology Physiological aspects Prevalence Prognosis Proportional Hazards Models Radiology Rare earth metal compounds Retrospective Studies Risk Factors Severity of Illness Index Sex Factors Time Factors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEA6yD-KLeLe6agRBUMr2msvjurgsgj65sG9hcikWtF1Oz-L-fGfS9LA94Poi9CE0aUpnvmS-NJMZxt41XrnQAuQ4dGTeVIXOFRZzJYJXlQZZ-hjt85s4O2--XLQXN1J9kU_YHB54FtxR3ZVCQyOLKoSmAasL5dAEIZFGruAhniMvdLEsptL-gZaFTHuYpRJHE1o1QU5bMqcj6fn1ygrFYP0rY7Q_O98wT_uuk3v7p9EsnT5g9xOf5Mfzdzxkd8LwiN39mnbMHzN3EiHgOPzCpXnvx6mfOF6XG4rzjd3zfuAjpermKcTqxOnfLIeRuuQIgiE-A4PnDja0sua_x80UOLl2xbon7Pz08_eTszwlVsgd0rdtrkE4AFd3UDqJ9qlSBSAvtLqGEgkJCC0DDlTfOqQTlv692TY0WKi1bb0t66fsYBiH8JxxJTrrbbCFFV0juxo05bhCVmKBynXGikXQxqWo45T84qeJqw8lzKwbg7oxpBtznbEPu0cu55AbtzX-RNrbNaRo2fEGYsgkDJl_YShj1aJ7sxxIxSkUO-pve_MbQomZz6vuJgpzTAkGBC5DRcbexxY0VeA3O0gnHlByFHRr1fJw1RKHuFtVv12QaKiK_OKGMF5NBoFOie2RNWbs2YzMnSgqXRF7RRXIFWZXslrXDP2PGGG8ldix0hn7uKDbpKlt-rtAXvwPVbxk9yoapuQwJA_ZwXZzFV4h7dva13GE_wHkzFIx priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9UwEA6ygvgirte6q0YQBKXYay6P68FlEfTJhX0LkzTFgrbL6VnWn-9MmpbtQReEPoRmksPJ3L5pkhnG3laNcr4GSFF1ZFoVmU4VNlMlfKMKDTJvQrbPb-LsvPpyUV_EZNF0F-bm_n2uxMcR_ZGg41YypcvkKcLFuzXaXRLmjdgsGwZaZjJuWv512MrthOz8K--zb45v-KP9s5J7G6bBD50-ZA8igOQnE8cP2R3fP2L3vsYt8sfMbQLPHYdfGIt3zTB2I8fnckuJvXF63vV8oNrcPOZUHTl9jOUw0JQcud6HMdA33MGWQml-PWxHz-ksV-h7ws5PP3_fnKWxkkLqEK_tUg3CAbiyhdxJdEiFygCBoNUl5IhAQGjpUTOb2iF-sPSxzda-wkapbd3YvHzKDvqh988ZV6K1jfU2s6KtZFuCpqJWCEMsULtMWDYvtHExzThVu_hpQrihhJl4Y5A3hnhjfifs_TLkcsqxcRvxJ-LeQkjpscMLlBoTtc2UbS40VDIrvK8qsDpTDnELRl8IMBuQCStm3pv5BiraTJyou-2XX5OUmOmC6mIZzAlVFBAYd4qEvQsUZBvwPzuIVxxw5SjL1oryeEWJOu1W3W9mSTTURQfhej9cjQYFnSrZI0xM2LNJMpelKHRBcBVZIFcyu1qrdU_f_QgpxWuJEyudsA-zdJtoy8Z_L8iL_6I-YvcL0kc6CiSP2cFue-VfIqDb2VdBlf8Aio9DwA priority: 102 providerName: Springer Nature |
| Title | Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1097664723011328 https://link.springer.com/article/10.1186/s12968-017-0415-x https://www.ncbi.nlm.nih.gov/pubmed/29212513 https://www.proquest.com/docview/1974007635 https://pubmed.ncbi.nlm.nih.gov/PMC5719789 https://doaj.org/article/3f169a4702ee44ab908c613174851da7 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1ri9QwMJx3IH4R31bPNYIgKNU-8_ggcrfceggeIi7st5CkqRbO9mz38Pz3zqTtapfzEJaSbdJsdx6ZmcxkhpDnWSGsy7UOgXV4mCWRDAU0Q8FcIRKpeVz4bJ8n7HiZfVjlqx0ylrcaANhdatphPalle_r64sevd8Dwbz3DC_amA5nFMCSLh3jgPASVcs-7izCSL_vjVJDcn54GHk_greRqcHJeOsVETPls_hNptb18_yW_tmMrtxysXm4tbpGbg8JJD3oKuU12XH2HXP84uNTvEjv3NGKp_g62e1U0XdVR-Jy1mAgcpqdVTRus5U2HHKwdxc1bqhuckgKV1P4ZXRfU6hZNb_qzaTtHMfbL990jy8XRl_lxOFReCC3od-tQama1tmmpY8tBgCUi0qA4GpnqGDQWzSR3wMlFbkHfMLg5Z3KXQSOVJi9MnN4nu3VTu4eEClaawjgTGVZmvEy1xCJYoLYYje00INEIaGWHtORYHeNUefNEMNXjRgFuFOJGXQTk5eaRsz4nx1WDDxF7m4GYTtvfaNqvauBOlZYxkzrjUeJclmkjI2FBzwFrDRTSQvOAJCPu1XhiFdZYmKi66pefIpWo_kDrZiVRB1iBgIGdygLywo9A6ob_bPVwJAIgh1m5JiP3JyNhDbCT7mcjJSrswsC52jXnnQKiz9DbmuYBedBT5gYUiUxQvQUU8AnNTmA17amrbz4Fec5hYiED8mqkbjWy7r8B8ug_3vIxuZEgF2LAEN8nu-v23D0BtW9tZuQaX3G4isX7Gdk7PDr59Bm-zdl85jdSZp7ZfwOXG1c7 |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA9SQX0Rv12tNoIgKIv7mY_HelhObfvUQt_CJJvFBd0tt1f0z3cm-0H30IJwD-Eym-MyM5lfdpLfMPa2qJTzJUCMriPjIkt0rLAZK-ErlWmQaRXYPk_F-rz4elFejGTRdBfmev4-VeJjj_FI0HErGdNl8hjh4m1KXBJN_kqs5oSBlokck5Z_fWwRdgI7_yL67C7H1-LR7lnJnYRpiENHD9j9EUDyw0HjD9kt3z5id07GFPlj5lZB547DT9yLN1XXNz3Hz-WGiL1xeN60vKPa3HzkVO05vYzl0NGQHLXehmegrbiDDW2l-a9u03tOZ7lC3xN2fvT5bLWOx0oKsUO8to01CAfg8hpSJzEgZSoBBIJW55AiAgGhpUfPrEqH-MHSyzZb-gIbubZlZdP8Kdtru9Y_Z1yJ2lbW28SKupB1DpqKWiEMsUDtPGLJNNHGjTTjVO3ihwnbDSXMoBuDujGkG_M7Yu_nRy4Hjo2bhD-R9mZBoscOX6DVmNHbTF6nQkMhk8z7ogCrE-UQt-DuCwFmBTJi2aR7M91AxTUTB2pu-uUDshIzXFCdVwZzSBUFBO47RcTeBQlaG_A_OxivOODMEcvWQnJ_IYk-7RbdbyZLNNRFB-Fa3131Bg2dKtkjTIzYs8Ey56nIdEZwFVUgFza7mKtlT9t8D5TipcSBlY7Yh8m6zbiW9f-ekBf_JX3A7q7PTo7N8ZfTby_ZvYx8k44FyX22t91c-VcI7rb2dXDrP-0-Rq8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA9ywuGLnN89Ty-CICjl-pmPx3N1Ob8OHzy4t5CkqRa0Xdo99M93Jk2LXfRA2IewmWbZzEzml2byG0KeF5WwrtQ6BtfhcZElMhbQjAVzlcik5mnl2T7P2dlF8f6yvAx1Tocp2306khzvNCBLU7s92VT16OKCnQwQpRgmYfEYr5jHACJvIlUX5vSt2Go-RpA84eEo86-PLYKR5-xfxKTdRfqPKLWbQblzjOqj0_qA3A6wkp6OdnCH3HDtXbL_KRyc3yN25S3BUv0DduhN1Q3NQOGz6ZHuG4anTUs7rNhNA9PqQPEVLdUdDknBFlr_jG4ranWPG2z6s-sHRzHDy_fdJxfrt19WZ3GorxBbQHHbWGpmtbZ5rVPLIUxlItEAD43MdQq4RDPJHfhrVVpAFQZfwZnSFdDIpSkrk-YPyF7bte4RoYLVpjLOJIbVBa9zLbHUFYATo7GdRySZJlrZQD6ONTC-K78JEUyNulGgG4W6Ub8i8nJ-ZDMyb1wn_Bq1Nwsiabb_ouu_quCDKq9TJnXBk8y5otBGJsICmoE9GcDOSvOIZJPu1XQvFVZSGKi57peP0UrUeG11Xi_UKdYZYLAbZRF54SVwxYD_bHW4-AAzh9xbC8mjhSR4ul10P5ssUWEXpse1rrsaFBg61rcH8BiRh6NlzlORyQxBLKiAL2x2MVfLnrb55onGSw4DCxmRV5N1q7DCDf-ekMP_kj4m-5_frNXHd-cfHpNbGbom5grxI7K37a_cE0B8W_PUe_VvRaBO_w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiac+amyloidosis+is+prevalent+in+older+patients+with+aortic+stenosis+and+carries+worse+prognosis&rft.jtitle=Journal+of+cardiovascular+magnetic+resonance&rft.au=Cavalcante%2C+Jo%C3%A3o+L&rft.au=Rijal%2C+Shasank&rft.au=Abdelkarim%2C+Islam&rft.au=Althouse%2C+Andrew+D&rft.date=2017-12-07&rft.issn=1532-429X&rft.eissn=1532-429X&rft.volume=19&rft.issue=1&rft.spage=98&rft_id=info:doi/10.1186%2Fs12968-017-0415-x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-6647&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-6647&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-6647&client=summon |